Junli Deng
Overview
Explore the profile of Junli Deng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
352
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu T, Deng J, Wang C, Li X, Ji J, Ben A
Plant Dis
. 2024 Jun;
PMID: 38840485
Hydrangea (Hydrangea macrophylla), commonly referred to as big leaf hydrangea, is a species within the Hydrangeaceae family notable for its ornamental value. Characterized by its vividly colored sepals and lush,...
2.
Deng J, Yao H, Shi P
Sensors (Basel)
. 2023 Oct;
23(20).
PMID: 37896498
Data-driven pose estimation methods often assume equal distributions between training and test data. However, in reality, this assumption does not always hold true, leading to significant performance degradation due to...
3.
Ma Y, Zhao W, Sun P, Deng W, Deng J, Zong H, et al.
Ann Transl Med
. 2023 Jan;
10(24):1372.
PMID: 36660622
Background: Apatinib is approved in China for the treatment of advanced gastric adenocarcinoma that had progressed or relapsed after standard systemic chemotherapy treatments. However, the effectiveness of Apatinib under real-world...
4.
Cui L, Deng J, Zhao L, Hu Y, Liu T
Front Microbiol
. 2022 Mar;
13:853202.
PMID: 35308383
is a heterothallic fungus that is the causal agent of northern leaf blight (NLB), which is a devastating foliar disease of sorghum and maize. Despite of its adversary to crop...
5.
Zhang X, Deng J, Chen J, Huang Y, Wu L
Ann Palliat Med
. 2021 Feb;
10(1):244-249.
PMID: 33545762
Background: Sepsis is an important disease that endangers human health and is the main cause of death in ICU patients, which has been a focus of clinical treatment. This study...
6.
Deng J, Bai X, Feng X, Ni J, Beretov J, Graham P, et al.
BMC Cancer
. 2019 Jun;
19(1):618.
PMID: 31234823
Background: Ovarian cancer is the most common malignant tumor of the female reproductive tract. Chemoresistance is a major challenge for current ovarian cancer therapy. However, the mechanism underlying epithelial ovarian...
7.
Deng J, Tang J, Wang G, Zhu Y
Int J Environ Res Public Health
. 2017 Mar;
14(3).
PMID: 28272371
Whole genome transcriptomic analyses have identified numerous long non-coding RNA (lncRNA) transcripts that are increasingly implicated in cancer biology. LncRNAs are found to promote essential cancer cell functions such as...
8.
Hao J, Graham P, Chang L, Ni J, Wasinger V, Beretov J, et al.
Oncotarget
. 2016 Oct;
7(45):74269-74285.
PMID: 27708237
Radioresistance is a major challenge for prostate cancer (CaP) metastasis and recurrence after radiotherapy. This study aimed to identify potential protein markers and signaling pathways associated with radioresistance using a...
9.
Deng J, Wang L, Ni J, Beretov J, Wasinger V, Wu D, et al.
Expert Rev Proteomics
. 2016 Sep;
13(10):905-915.
PMID: 27598304
Chemoresistance is a major challenge to current ovarian cancer chemotherapy. It is important to identify biomarkers to distinguish chemosensitive and chemoresistant patients. Areas covered: We review the medical literature, discuss...
10.
Deng J, Wang L, Chen H, Hao J, Ni J, Chang L, et al.
Oncotarget
. 2016 Jun;
7(34):55771-55788.
PMID: 27304054
Chemoresistance is the main challenge for the recurrent ovarian cancer therapy and responsible for treatment failure and unfavorable clinical outcome. Understanding mechanisms of chemoresistance in ovarian cancer would help to...